Prevalence of Dissociative Identity Disorder in At-risk Outpatient Groups Reporting Childhood Trauma.
NCT ID: NCT06330467
Last Updated: 2024-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
350 participants
INTERVENTIONAL
2024-06-04
2026-08-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators will also study the prevalence of other dissociative disorders and the frequency of complex post-traumatic stress disorder.
The investigators will also look for correlations between the type of maltreatment in childhood, the age of onset of trauma and the type of diagnosis of dissociative disorders.
The investigators hope to include 150 borderline patients, 150 FDC patients and 50 early psychosis patients.
Data collection will be done via a psychometric administration of 7 self-completion questionnaires as well as the completion of the SCID-D semi-structured interview.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Dissociative Traumatic Disorders
NCT04379648
Study of Emotional Dysregulation in Complex Post-Traumatic Stress Disorder
NCT06848127
Identification of Post-Traumatic Stress Disorder in Adult Patients With Substance Use Disorders
NCT06432400
Evaluating the Neurobiological Basis of Traumatic Dissociation in Women With Histories of Abuse and Neglect
NCT02757339
Psychological Therapy for Dissociation, Trauma and Voices: A Single Case Experimental Design
NCT04127526
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Borderline
Borderline patients
psychometric assessment
Psychometric testing to assess trauma and dissociative disorders, and in particular dissociative identity disorder.
semi-structured clinical interview
Semi-structured interview for the assessment of dissociative disorders (SCID-D : Semi-structured Clinical Interview for diagnosing DSM-5 and ICD-11 Dissociative Disorders)
Functional Dissociative Crises (FDC)
FDC patients
psychometric assessment
Psychometric testing to assess trauma and dissociative disorders, and in particular dissociative identity disorder.
semi-structured clinical interview
Semi-structured interview for the assessment of dissociative disorders (SCID-D : Semi-structured Clinical Interview for diagnosing DSM-5 and ICD-11 Dissociative Disorders)
Early psychosis
Early psychosis patients : mental state at risk for psychosis and first psychotic episode
psychometric assessment
Psychometric testing to assess trauma and dissociative disorders, and in particular dissociative identity disorder.
semi-structured clinical interview
Semi-structured interview for the assessment of dissociative disorders (SCID-D : Semi-structured Clinical Interview for diagnosing DSM-5 and ICD-11 Dissociative Disorders)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
psychometric assessment
Psychometric testing to assess trauma and dissociative disorders, and in particular dissociative identity disorder.
semi-structured clinical interview
Semi-structured interview for the assessment of dissociative disorders (SCID-D : Semi-structured Clinical Interview for diagnosing DSM-5 and ICD-11 Dissociative Disorders)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or female
* Age \> or = 18
* Enrolled in or benefiting from a social security scheme
* Patient fluent in French
* Patient willing to undergo a psychological evaluation between 1h30 and 3h30
* Patient with a known history of psychotrauma in childhood before the age of 18 (sexual abuse, mistreatment, school harassment, natural disasters, attacks, etc.).
* Patient having received and understood complete information on the organization of the research and having given written free and informed consent prior to participation in the study.
I-2 : Patients in the borderline group
* Patients with main diagnosis of emotionally labile personality
* Patients with at least one psychiatric hospitalization in the last 3 years
I-3 : Patients in the early psychosis group
Patient with a diagnosis of mental state at risk of psychosis according to the criteria defined by CAARMS (Comprehensive Assessment of At Risk Mental State) OR Patients diagnosed with a first psychotic episode on an outpatient basis or following a hospital stay
I-4 : Patients in the functional dissociative crises group
Patients diagnosed with functional dissociative crises by a specialized epileptologist
* Impairment of the subject making it difficult or not impossible to participate in the trial or to understand the information provided to him/her
* Patients with specific difficulties in understanding SCID-D questions
* Psychiatric condition requiring hospitalization
* Patients with symptoms of recent toxic consumption (alcohol, cannabis, other ...) disrupting assessment responses
* Patient taking part in a pharmacological study involving a pro-dissociative molecule of the psychedelic type
* Pregnant, parturient or nursing mothers
* Person deprived of liberty by judicial or administrative decision
* Person in a life-threatening emergency
* An adult under legal protection (guardianship, curatorship, safeguard of justice)
* Person unable to give consent and not subject to a legal protection measure
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Psychothérapique de Nancy
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Coraline HINGRAY
Role: PRINCIPAL_INVESTIGATOR
Centre Psychothérapique de Nancy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Centre Psychothérapique de Nancy - CLIP
Nancy, , France
Centre Psychothérapique de Nancy - CMP Jacquard et Des Près
Nancy, , France
CHRU Nancy - Neurology department
Nancy, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RIPH 2023-02
Identifier Type: REGISTRY
Identifier Source: secondary_id
2023-A02442-43
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.